Garvan Institute and Pharmaxis Collaboration for PXS-5505 – Researchers at the Garvan Institute of Medical Research, in collaboration with Australian pharmaceutical company Pharmaxis, have made a significant discovery regarding an experimental treatment for bone marrow cancer. The drug, named PXS-5505, shows promise in treating pancreatic…